BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20494218)

  • 1. Introduction. The human papillomavirus VLP vaccines.
    Stanley M
    Gynecol Oncol; 2010 Jun; 118(1 Suppl):S1. PubMed ID: 20494218
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards global prevention of human papillomavirus-induced cancer.
    Roden RB; Gravitt P; Wu TC
    Eur J Immunol; 2008 Feb; 38(2):323-6. PubMed ID: 18228245
    [No Abstract]   [Full Text] [Related]  

  • 3. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types.
    Herrero R
    J Infect Dis; 2009 Apr; 199(7):919-22. PubMed ID: 19236278
    [No Abstract]   [Full Text] [Related]  

  • 4. GARDASIL: prophylactic human papillomavirus vaccine development--from bench top to bed-side.
    Shi L; Sings HL; Bryan JT; Wang B; Wang Y; Mach H; Kosinski M; Washabaugh MW; Sitrin R; Barr E
    Clin Pharmacol Ther; 2007 Feb; 81(2):259-64. PubMed ID: 17259949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunobiology of HPV and HPV vaccines.
    Stanley M
    Gynecol Oncol; 2008 May; 109(2 Suppl):S15-21. PubMed ID: 18474288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential mechanisms for HPV vaccine-induced long-term protection.
    Stanley M
    Gynecol Oncol; 2010 Jun; 118(1 Suppl):S2-7. PubMed ID: 20494220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum human papillomavirus vaccines: new horizons but one step at a time.
    Bosch FX
    J Natl Cancer Inst; 2009 Jun; 101(11):771-3. PubMed ID: 19470950
    [No Abstract]   [Full Text] [Related]  

  • 9. HPV vaccine gets a shot in the arm.
    Honey K
    J Clin Invest; 2006 Dec; 116(12):3087. PubMed ID: 17143319
    [No Abstract]   [Full Text] [Related]  

  • 10. [Human papillomavirus vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008].
    Abarca V K; Valenzuela B MT; Vergara F R; Luchsinger F V; Muñoz M A; Jiménez de la Jara J; Ripoll M E; O'Ryan G M
    Rev Chilena Infectol; 2008 Dec; 25(6):428-34. PubMed ID: 19194605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccines: WHO position paper.
    Who
    Biologicals; 2009 Oct; 37(5):338-44. PubMed ID: 19525124
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlating immunity with protection for HPV infection.
    Frazer I
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S10-6. PubMed ID: 18162240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus vaccines.
    Satyaprakash A; Creed R; Ravanfar P; Mendoza N
    Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the burden of cervical cancer and HPV-related diseases through vaccination. Introduction.
    Cox JT
    Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s3-4. PubMed ID: 16520682
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
    Coupé VM; Meijer CJ; Berkhof J
    J Natl Cancer Inst; 2010 Mar; 102(5):358; author reply 358. PubMed ID: 19861306
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccine policy analyses can benefit from natural history studies of human papillomavirus in men.
    Kim JJ
    J Infect Dis; 2007 Oct; 196(8):1117-9. PubMed ID: 17955427
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccines for the prevention of human papillomavirus infections.
    Speck LM; Tyring SK
    Skin Therapy Lett; 2006; 11(6):1-3. PubMed ID: 16912836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring serum antibody to human papillomavirus following infection or vaccination.
    Frazer IH
    Gynecol Oncol; 2010 Jun; 118(1 Suppl):S8-11. PubMed ID: 20494221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-like particle vaccines and adjuvants: the HPV paradigm.
    Buonaguro FM; Tornesello ML; Buonaguro L
    Expert Rev Vaccines; 2009 Oct; 8(10):1379-98. PubMed ID: 19803760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-utility analysis of vaccination against HPV in Israel.
    Ginsberg GM; Fisher M; Ben-Shahar I; Bornstein J
    Vaccine; 2007 Sep; 25(37-38):6677-91. PubMed ID: 17706844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.